P426

Prevalence of the phyto-oestrogen urinary metabolites enterodiol and enterolactone in patients under endocrine investigation

L Reilly, L Scobbie, CA Dorrian & AM Wallace

P427

Comparative review of primary and secondary empty sella syndrome

MB Babarina, IA Gracheva & EI Marova

P428

Adult's primary empty sella

M Rezzoug, L Zadoud, L Cherf & F Chentli

P429

The UV filter benzophenone 2 inactivates human recombinant thyroperoxidase in vitro and disturbs thyroid hormone homeostasis in rats

C Schmutzler, A Bacinski, P Ambrugger, H Klammer, W Wuttke, A Grüters, H Jarry & J Köhrle

P430

Endocrine disorders in thalassaemia - local experience in an inner city hospital in Birmingham, England

KK Gangopadhyay, G Das, W Burbridge, C Wright & P De

P431

Extracts of black cohosh (Actaea racemosa) inhibit growth of MCF-7 and MDA-MB-231 breast cancer cells and dose-dependently inhibit oestrone sulphatase activity

SA Whitehead, C Kotalla, S Rice & HD Mason

P432

Androgen-dependent Sertoli cell proliferation as a target for endocrine disruptors relevant to human male reproductive health

H Scott, N Hallmark, PTK Saunders, G Verhoeven, K De Gendt, G Hutchison & RM Sharpe

P433

A randomized, open-label, multicenter study to evaluate octreotide LAR with surgical therapy as primary therapy in patients with acromegaly

A Colao, H Bouterfa, P Cappabianca, P Caron, E De Menis, A Farrall, M Gadelha, A Reed, M Reincke, M Safari, G T'Sjoen & R Cuneo

P434

Origin of dysgenetic areas in testes of rats exposed to di-n-butyl phthalate (DBP) during fetal life: a model of human testicular dysgenesis syndrome

IK Mahood, HM Scott, N Hallmark, C McKinnell, M Walker, JS Fisher & RM Sharpe

P435

Endocrine disruptors and idiopathic gynecomastia with aromatase gene polymorphism

IK Czajka, S Zgliczynski & W Zgliczynski

P436

Loss and resumption of ovarian function after mitotane administration

I Kostoglou-Athanassiou, M Goula, P Athanassiou & PH Kaldrymidis